首页> 外文期刊>Clinical and experimental hypertension: CEH >Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.
【24h】

Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.

机译:最近在瑞典开始的高血压干预试验-HOT,CAPPP等。高血压最佳治疗研究。卡托普利预防项目。

获取原文
获取原文并翻译 | 示例
           

摘要

In 1998 the final results were presented of two large intervention trials in hypertension, the Hypertension Optimal Treatment Study (HOT) and the Captopril Prevention Project (CAPPP). Both were initiated from Sweden although the HOT Study was conducted in 26 countries worldwide and the CAPPP Study in Finland and Sweden. The HOT and CAPPP trials and their principal results will be reviewed briefly here. In addition a brief up-date will be provided of three ongoing intervention trials in hypertension that were also initiated from Sweden: the Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-), the Nordic Diltiazem (NORDIL) Study and the Study on Cognition and Prognosis in Elderly Hypertensives (SCOPE).
机译:1998年,发表了两项针对高血压的大型干预试验的最终结果,即高血压最佳治疗研究(HOT)和卡托普利预防项目(CAPPP)。两者都是从瑞典发起的,尽管HOT研究在全球26个国家进行,而CAPPP研究则在芬兰和瑞典进行。 HOT和CAPPP试验及其主要结果将在这里进行简要回顾。此外,还将简要介绍由瑞典发起的三项正在进行的高血压干预试验的最新进展:瑞典对老年高血压2(STOP-Hypertension-)患者的试验,北欧地尔硫卓(NORDIL)研究和老年高血压的认知和预后研究(SCOPE)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号